NCT03250585View on ClinicalTrials.gov

sPLA2 in EBC During Acute Chest Syndrome

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

January 19, 2018

Primary Completion Date

June 14, 2018

Study Completion Date

June 14, 2018

Conditions
Sickle Cell DiseaseAcute Chest Syndrome
Interventions
DIAGNOSTIC_TEST

Exhaled Breath Condensate (EBC)

Serial EBC samples will be collected within 48 hours of acute chest syndrome (ACS) diagnosis and at 2 week follow up

DIAGNOSTIC_TEST

Plasma Sample

Serial plasma samples will be collected within 48 hours of acute chest syndrome (ACS) diagnosis and at 2 week follow up

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER

NCT03250585 - sPLA2 in EBC During Acute Chest Syndrome | Biotech Hunter | Biotech Hunter